NYSE: CVS | Healthcare / Healthcare Plans / USA |
86.40 | -1.09 | -1.25% | Vol 5.17M | 1Y Perf -19.66% |
Feb 2nd, 2023 12:38 DELAYED |
BID | 86.39 | ASK | 86.40 | ||
Open | 86.54 | Previous Close | 87.49 | ||
Pre-Market | 87.00 | After-Market | - | ||
-0.49 -0.56% | - - |
Target Price | 117.25 | Analyst Rating | Moderate Buy 1.62 | |
Potential % | 35.50 | Finscreener Ranking | ★+ 42.42 | |
Insiders Trans % 3/6/12 mo. | -100/-89/-79 | Value Ranking | ★ 39.68 | |
Insiders Value % 3/6/12 mo. | -100/-99/-98 | Growth Ranking | ★★ 44.60 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-99/-98 | Income Ranking | ★ 31.27 | |
Price Range Ratio 52W % | 5.98 | Earnings Rating | Neutral | |
Market Cap | 113.53B | Earnings Date | 8th Feb 2023 | |
Alpha | 0.00 | Standard Deviation | 0.08 | |
Beta | 0.77 |
Today's Price Range 85.4686.97 | 52W Range 84.82111.25 | 5 Year PE Ratio Range -89.2019.20 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | -0.19% | ||
1 Month | -6.12% | ||
3 Months | -9.62% | ||
6 Months | -8.26% | ||
1 Year | -19.66% | ||
3 Years | 29.00% | ||
5 Years | 14.44% | ||
10 Years | 76.50% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 7.61 | |||
ROE last 12 Months | 4.72 | |||
ROA (5Y Avg) | 1.85 | |||
ROA last 12 Months | 1.47 | |||
ROC (5Y Avg) | 5.28 | |||
ROC last 12 Months | 3.37 | |||
Return on invested Capital Q | -2.05 | |||
Return on invested Capital Y | 1.19 | |||
Assets Turnover | 1.10 | |||
Receivables Turnover | 10.00 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
39.10 | ||||
1.70 | ||||
0.50 | ||||
5.50 | ||||
10.20 | ||||
16.67 | ||||
-3.70 | ||||
53.79 | ||||
171.44B | ||||
Forward PE | 9.94 | |||
PEG | 5.36 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.60 | ||||
0.90 | ||||
0.49 | ||||
1.01 | ||||
2.70 | ||||
Leverage Ratio | 3.20 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
17.20 | ||||
2.00 | ||||
3.40 | ||||
2.90 | ||||
0.78 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
238.62B | ||||
181.60 | ||||
9.47 | ||||
11.35 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.65 | ||||
2.42 | ||||
0.24 | ||||
1.44 | ||||
Payout ratio | 35.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2022 | 1.99 | 2.09 | 5.03 |
Q02 2022 | 2.16 | 2.40 | 11.11 |
Q01 2022 | 2.14 | 2.22 | 3.74 |
Q04 2021 | 1.94 | 1.98 | 2.06 |
Q03 2021 | 1.79 | 1.97 | 10.06 |
Q02 2021 | 2.07 | 2.42 | 16.91 |
Q01 2021 | 1.72 | 2.04 | 18.60 |
Q04 2020 | 1.24 | 1.30 | 4.84 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2022 QR | 1.91 | -1.04 | Negative |
12/2022 FY | 8.62 | 1.06 | Positive |
3/2023 QR | 2.24 | -0.88 | Negative |
12/2023 FY | 8.83 | -4.13 | Negative |
Next Report Date | 8th Feb 2023 |
Estimated EPS Next Report | 1.92 |
Estimates Count | 6 |
EPS Growth Next 5 Years % | 7.30 |
Volume Overview | |
---|---|
Volume | 5.17M |
Shares Outstanding | 1.31M |
Shares Float | 1.31B |
Trades Count | 56.41K |
Dollar Volume | 447.13M |
Avg. Volume | 8.29M |
Avg. Weekly Volume | 7.76M |
Avg. Monthly Volume | 10.04M |
Avg. Quarterly Volume | 7.06M |
CVS Health Corporation (NYSE: CVS) stock closed at 87.49 per share at the end of the most recent trading day (a -0.83% change compared to the prior day closing price) with a volume of 6.71M shares and market capitalization of 113.53B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.
The one-year performance of CVS Health Corporation stock is -19.66%, while year-to-date (YTD) performance is -6.12%. CVS stock has a five-year performance of 14.44%. Its 52-week range is between 84.82 and 111.25, which gives CVS stock a 52-week price range ratio of 5.98%
CVS Health Corporation currently has a PE ratio of 39.10, a price-to-book (PB) ratio of 1.70, a price-to-sale (PS) ratio of 0.50, a price to cashflow ratio of 5.50, a PEG ratio of 2.32, a ROA of 1.47%, a ROC of 3.37% and a ROE of 4.72%. The company’s profit margin is 0.78%, its EBITDA margin is 3.40%, and its revenue ttm is $238.62 Billion , which makes it $181.60 revenue per share.
Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.92 for the next earnings report. CVS Health Corporation’s next earnings report date is 08th Feb 2023.
The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.62), with a target price of $117.25, which is +35.50% compared to the current price. The earnings rating for CVS Health Corporation stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CVS Health Corporation has a dividend yield of 2.65% with a dividend per share of $2.42 and a payout ratio of 35.00%.
CVS Health Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 8.01, ATR14 : 1.55, CCI20 : -53.68, Chaikin Money Flow : -0.16, MACD : -1.94, Money Flow Index : 40.14, ROC : -2.70, RSI : 37.96, STOCH (14,3) : 46.52, STOCH RSI : 0.85, UO : 53.14, Williams %R : -53.48), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan M. Lotvin (Option Excercise at a value of $8 245 943), Alan M. Lotvin (Sold 143 440 shares of value $14 192 366 ), Daniel P. Finke (Option Excercise at a value of $2 960 553), Daniel P. Finke (Sold 70 846 shares of value $7 091 795 ), Edward J. Ludwig (Buy at a value of $105 904), Prem S. Shah (Option Excercise at a value of $1 716 473), Prem S. Shah (Sold 26 924 shares of value $2 833 046 ), Thomas M. Moriarty (Option Excercise at a value of $23 903 792), Thomas M. Moriarty (Sold 327 481 shares of value $32 086 214 ), Troyen A. Brennan (Option Excercise at a value of $4 902 037), Troyen A. Brennan (Sold 47 937 shares of value $5 273 070 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Strong Buy | Strong Buy |
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with over 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
CEO: Karen S. Lynch
Telephone: +1 401 765-1500
Address: One CVS Drive, Woonsocket 02895, RI, US
Number of employees: 300 000
Tue, 08 Nov 2022 12:45 GMT CVS Health (CVS) Receives a Hold from Wells Fargo
- TipRanks. All rights reserved.Sat, 17 Sep 2022 13:17 GMT IBM, CVS among cheap stocks not deserving to be in bargain bin, Barrons says
- TipRanks. All rights reserved.Mon, 05 Sep 2022 06:43 GMT CVS Health (NYSE:CVS) Races Ahead to Buy Signify Health
- TipRanks. All rights reserved.Fri, 05 Aug 2022 12:45 GMT CVS Health (CVS) Receives a Buy from Jefferies
- TipRanks. All rights reserved.Mon, 04 Jul 2022 22:17 GMT CVS Health Stock: A Recession-Proof Cash Cow
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.